Ascomycin

Ascomycin
Product Description

ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Biopharmaceutical
Contract Manufacturer
Cosmetic Ingredients
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals
Pharmaceutical Company (generic finished products)

ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    5000+
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Biopharmaceutical
Contract Manufacturer
Cosmetic Ingredients
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Intermediates Manufacturer
Nutraceuticals
Pharmaceutical Company (generic finished products)

More Products from ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (99)

  • Anastrozole

    Product Anastrozole

    Oncology APIUSP, ChP+YBH
    USDMF(Submitted), CN Status(A)
  • Anidulafungin

    Product Anidulafungin

    Therapeutic Area:Infection

    Status:Pilot

  • Apalutamide

    Product Apalutamide

    Therapeutic Area:Oncology

    Status:Pilot

  • Apixaban

    Product Apixaban

    Cardiovascular APIYBY
    CN Status(A)
  • Apremilast

    Product Apremilast

    Immunology APIIn house
    CN Status(A)
  • Aripiprazole

    Product Aripiprazole

    USP, ChP+YBYUSDMF, CN Status(A)
  • avacopan

    Product avacopan

    Therapeutic Area: ANCA-Associated Vasculitis(AAV) ANCA

    Status: Early

  • Baloxavir Marboxil

    Product Baloxavir Marboxil

    Therapeutic Area: Influenza

    Status: Early

  • Bedaquiline Fumarate

    Product Bedaquiline Fumarate

    Anti-infection APIIn house
    CN Status(A)
  • Belumosudil

    Product Belumosudil

    Therapeutic Area: Immunology

    Status: Early

  • Bicalutamide

    Product Bicalutamide

    Oncology APIUSP, EP, ChP+YBH
    USDMF, CN Status(A)
  • Bleomycin Sulfate

    Product Bleomycin Sulfate

    Oncology APIUSP, EP, IP
    USDMF, CEP